Coxsackie virus infections and heart disease by Brown, Gordon C.
American Heart Journal 
Editorial 
Coxsackie virus infections and heart disease 
Gordon C. Brown, Sc.D. 
AWI. Arbor, iWich. 
T he causative factors of most congenital anomalies remain unknown in spite 
of voluminous literature published on the 
subject during the last three decades. The 
relatively large number of known determi- 
nants of abnormalities, such as genetic 
factors, chromosomal aberrations, endo- 
crine disturbances, drugs and chemicals, 
radiation, physical injury, malnutrition, 
and infection, although well documented, 
leave more than 50 per cent of anomalous 
births unexplained. In fact, several recent 
surveys have estimated that less than 2 
per cent of anomalous infants were known 
to have been exposed to proved terato- 
genie agents. One of the most frequently 
encountered abnormal conditions of the 
infant is congenital heart disease. This 
defect has been observed to occur approxi- 
mately six times in every 1,000 live births.1-3 
As stated in a recent review by Higgins,4 
the causes of malformations of the heart 
remain essentially unknown. The relative 
role of hereditary and environmental fac- 
tors has been subject to considerable 
investigation in recent years,1-5 but, with 
the exception of rubella virus, genetic 
factors, and recessive inheritance, little 
is known of the etiology of this condition. 
Furthermore, except for epidemic years, 
only about 2 per cent of the malformations 
of the heart have been shown to be caused 
by rubella infections.’ 
Other viruses, and Coxsackie viruses in 
particular, represent logical targets for 
incrimination as teratogenic agents.6 The 
affinity of these infectious agents for heart 
tissue has become increasingly well docu- 
mented in recent years. Experimental 
studies in young mice and in monkeys by 
Burch, DePasquale, and their associates,7-g 
have demonstrated that Coxsackie type 
B4 virus induces both valvular and mural 
endocarditis in significant numbers of 
infected animals. Of added significance is 
the fact that virus was recovered from heart 
tissue and was also detected in situ by the 
fluorescent antibody technique, which sug- 
gests strongly that the virus is capable of 
invading the endocardium. Lou, Wenner, 
and KamitsukalO also produced mural 
endocarditis and mitral valvulitis in mon- 
keys with this agent. Burch and his groupll 
have extended their studies to man where 
group B Coxsackie viruses were identified 
by the FA procedure in 17 of 55 hearts 
obtained at autopsy. A high percentage of 
the virus-positive specimens were from 
children and infants, some of whom were 
premature or anomalous. 
The ability of these agents to cause 
myocarditis in adultsl” and especially in 
the newborn child is well documented.13J4 
Many infants with neonatal myocarditis 
appear to have acquired the infection 
during the intrauterine period and, sig- 
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nificantly, their mothers characteristically 
showed no more than mild illness or com- 
pletely subclinical infection. 
The widespread occurrence of these in- 
fections which are predominantly sub- 
clinical in adults, the viremia which would 
enable such very small agents (28 mp) to 
cross the placental barrier easily, and the 
proved greater susceptibility of young, 
rapidly metabolizing tissue to viruses, all 
together point clearly to the fetus as a 
logical target for invasion and subsequent 
damage in the form of congenital heart 
disease. Evidence which strongly suggests 
that this is the case has recently been re- 
ported by Brown and Evans.15 Over 10,000 
pregnant women were studied prospec- 
tively, and paired sera of mothers of anom- 
alous infants together with matched speci- 
ments from mothers of normal children 
were tested for serologic evidence of infec- 
tion with various viruses during pregnancy. 
A significantly greater incidence of infec- 
tion with Coxsackie group B and type A9 
viruses was observed in mothers of infants 
with congenital heart disease than in 
their matched controls. Types B3 and 4 
were most frequently associated with mal- 
formed infant hearts. The greater fre- 
quency of maternal infection associated 
with abnormal infants was observed re- 
gardless of the severity of the condition, 
which ranged from ventricular or atria1 
septal defects, aortic or tricuspid atresia, 
and transposition of great vessels to mild 
patent ductus arteriosus and low-grade 
murmurs. Inclusion of this latter category 
was felt to be justified in view of other 
reports of the development of diastolic and 
systolic murmurs in patients several months 
after recovery from group B Coxsackie 
virus myocarditis. 16 Rubella associated con- 
genital heart cases were discarded from 
the evaluation and, although infections 
with other viruses were detected, their 
occurrence was essentially the same in 
both the anomaly and the cont.rol groups. 
Final proof of the incidence of congenital 
heart disease induced by Coxsackie virus 
must await extended and additional sero- 
logic studies as well as virologic evidence 
through isolation or visualization in af- 
fected heart tissue. In the meantime the 
pursuit of studies such as described herein 
constitutes an exciting approach to the 
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